In the present study we aimed to assess the underlying signaling pathway (E-cadherin-dependent) involved in the regulation of the bisecting GlcNAcN-glycans in the process of tumor progression of epithelial cancer cells

In the present study we aimed to assess the underlying signaling pathway (E-cadherin-dependent) involved in the regulation of the bisecting GlcNAcN-glycans in the process of tumor progression of epithelial cancer cells. We have evaluated the impact of E-cadherinde novoexpression in the activity of different receptors tyrosine kinase using an epithelial cancer cell model. of epithelial characteristics and tumor cell invasion. Here we provide new insights into the role that Insulin/IGF-I signaling play during cancer progression through glycosylation modifications. == Introduction == The Insulin Growth Factor (IGF) system in mammals comprises a dynamic network of proteins including ligands (IGF-I and IGF-II) and at least four associated receptors. The insulin receptor (IR), IGF-I receptor (IGF-IR), and insulin receptor-related receptor (IRR) belong to the tyrosine-kinase superfamily [1]. Insulin/IGF-I signaling pathways play a crucial role during malignant transformation [2]. The activation of these pathways has been related with increased proliferation, survival, metastatic potential and angiogenesis [3]. Therefore, the Insulin/IGF-I signaling pathway has been considered an appealing therapeutic target in cancer [4]. In this context, it was demonstrated that tumor growth in human tumor xenograft models was significantly reduced by using antibodies that inhibit the Insulin/IGF-I signaling [5,6]. Moreover, daily Apiin treatment with OSI-906, a dual inhibitor of the IGF-I and insulin receptors, resulted in tumor growth inhibition in the NCI-H292 xenografts [7]. Furthermore, recent studies have point out the importance of the insulin/IGF-I signaling in the loss of epithelial features of carcinoma cells [8,9]. It was shown that IGF-I increases invasive potential inducing TGF-1-mediated Epithelial to Mesenchymal Transition (EMT) in MCF-7 breast cancer cells [8]. E-cadherin is a cell-cell adhesion molecule with pivotal roles in the suppresion of tumor cell invasion and metastasis, being also a key molecular player in the EMT process [10]. Dysfunction of E-cadherin is considered a major event of more than 70% of human invasive carcinomas. Several mechanisms have been recently proposed to underlie E-cadherin down-regulation or inactivation in cancer, such as post-translational modifications byN-glycosylation Apiin [1115]. It has been our long last interest to understand the role that glycans play during the carcinogenic process, particularly in the modulation and regulation of E-cadherin biological functions. In this context, we have previously demonstrated that E-cadherin functions can be specifically modulated by the presence of different oligosaccharide structures [1517]. We have shown that during the acquisition of the malignant phenotype, E-cadherin suffered an increased modification with 1,6 GlcNAc branchedN-glycans, catalyzed byN-acetylglucosaminyltransferase V (GnT-V) [18,19], that was further demonstrated to induce a destabilization of E-cadherin-mediated cell-cell adhesion (adherens junction) with consequences to tumor progression [17]. Furthermore, it was shown the existence a bidirectional cross-talk between E-cadherin expression and theN-acetylglucosaminyltransferase Apiin III (GnT-III) [19,20]. The modification of E-cadherin with bisecting GlcNAcN-glycans, catalyzed by GnT-III, was shown to enhance cellcell adhesion with increased stability of adherens junctions, Rabbit Polyclonal to OR2H2 which was associated with suppression of tumor progression [17,21]. In addition, the modification of the growth receptors with bisecting GlcNAc structures precludes their membranar stabilization and consequently their signaling activation, through the inhibition of further extension and elongation of theN-glycans with 1,6 GlcNAc branched structures [22,23] . Taking into consideration the existence of a functional feedback loop between E-cadherin-mediated cell-cell adhesion and bisecting GlcNAcN-glycans in the suppression of cancer cell invasion, it remains to be identified which are the associated signaling pathways involved in this process. In this study, we aim to identify the E-cadherin-dependent signaling pathway involved in the regulation ofN-glycosylation, particularly in the expression of bisecting GlcNAcN-glycans and their impact on the malignant phenotype of MDA-MB435 epithelial cancer cells. We herein demonstrate for the first time that on one hand E-cadherin expression induces a significant decrease in the phosphorylation levels of insulin and IGF-I receptors, which was accompanied with an increased modification of E-cadherin with bisecting GlcNAc structures, and a consequent suppression of tumor cell invasion. On the other hand, the activation of the insulin and IGF-1 signaling pathways induces a significant decrease of the bisecting GlcNAcN-glycans in general, and.